KinesisDx
KinesisDx is a Delaware-based biotechnology company specializing in the manufacture of high-quality monoclonal, polyclonal, and recombinant antibodies for research and diagnostics. The company offers a diverse portfolio of rigorously validated antibodies optimized for a broad spectrum of biomedical applications including Western Blotting, Immunohistochemistry, Flow Cytometry, ELISA, Immunoprecipitation, and Immunofluorescence. KinesisDx differentiates itself through scientific rigor, reproducibility, lot-to-lot consistency, and custom antibody development services. Their products support research in immunology, oncology, neuroscience, infectious diseases, and other fields. The company emphasizes innovation with advanced methodologies such as phage display technology, recombinant antibody humanization, and AI-assisted epitope mapping. KinesisDx serves the scientific research community with validated antibody reagents and technical support, positioning itself as a trusted partner in accelerating scientific breakthroughs.
KinesisDx
KinesisDx is a Delaware-based biotechnology company specializing in the manufacture of high-quality monoclonal, polyclonal, and recombinant antibodies for research and diagnostics. The company offers a diverse portfolio of rigorously validated antibodies optimized for a broad spectrum of biomedical applications including Western Blotting, Immunohistochemistry, Flow Cytometry, ELISA, Immunoprecipitation, and Immunofluorescence. KinesisDx differentiates itself through scientific rigor, reproducibility, lot-to-lot consistency, and custom antibody development services. Their products support research in immunology, oncology, neuroscience, infectious diseases, and other fields. The company emphasizes innovation with advanced methodologies such as phage display technology, recombinant antibody humanization, and AI-assisted epitope mapping. KinesisDx serves the scientific research community with validated antibody reagents and technical support, positioning itself as a trusted partner in accelerating scientific breakthroughs.